| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |